A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Phase 1
230
about 5.6 years
18+
17 sites in CA, CO, CT +7
About this study
Researchers are testing a treatment called NST-628 for adults with solid tumors that have not responded to other treatments. The trial will evaluate how safe and effective this treatment is.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take NST-628
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Primary: Part B: Evaluate objective tumor response rate
Secondary: Part A and B: Characterize the pharmacokinetics of NST-628, Part A and B: Evaluate overall survival (OS), Part A and B: Evaluate progression free survival (PFS), Part A: Evaluate objective tumor response rate
Oncology